Nazli Albayrak

Nazli Albayrak

Auto-generated profile, based on publicly available information

Nazli Albayrak

Beşiktaş, İstanbul, Turkey

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2022 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
ECElif Gizem Carus
Elif Gizem Carus
NANazli Albayrak
Nazli Albayrak
HBHalit Mert Bildirici
Halit Mert Bildirici
SOSelen Gur Ozmen
Selen Gur Ozmen
Objective: To evaluate the effectiveness of immersive virtual reality (VR) on patient satisfaction as a distractive tool and pain relief among laboring women. Methods: This was a randomized, controlled clinical trial with 42 laboring women allocated to VR intervention and control groups. Among women in the VR group, patient satisfaction with the use of VR was assessed by a Virtual Reality Satisfaction Survey, measured by a Visual Analog Scale (VAS) score and evaluated by questioning them about whether they would choose VR in future labor. As a primary outcome, patient satisfaction scores regarding the overall childbirth experience were compared between women in the two groups. A secondary outcome was pain assessed by a visual pain rating scale in the early and active phases of labor in women in both groups. Psychometric information was also collected from participants in each group using the Beck Anxiety Inventory and Beck Depression Inventory. Results: We observed a high level of patient satisfaction with the use of immersive VR during labor. The VAS revealed a mean satisfaction score of 87.7 ± 12.9 out of a maximum of 100. Twenty out of 21 (95%) women in the VR group stated that they would like to use VR again in future labor. VR improved pain scores in early labor and contributed positively to the overall childbirth experience. The mean pain score pre-VR was 2.6 ± 1.2 compared to 2.0 ± 1.3 post-VR (p < 0.01). Anxiety and depression scores were similar in participants in the intervention and control groups (p = 0.103 and p = 0.13, respectively). Conclusion: Immersive VR application during labor was associated with higher patient satisfaction based on our study findings. VR also improved participants’ pain scores in early labor before epidural administration. Immersive VR may find a place as an adjunct in labor and delivery units to improve lengthy labor experiences for women. Studies with larger groups of participants are needed to confirm these observations. Trial Registration: ClinicalTrials.gov: NCT05032456

23 June 2023 in Journal of Assisted Reproduction and Genetics
Verified
Journal Article
Closed access
PDF file
TATurgut Aydin
Turgut Aydin
NKNadiye köroğlu
Nadiye köroğlu
NANazli Albayrak
Nazli Albayrak
Mert Akin InselMert Akin Insel
Mert Akin Insel

15 July 2026 in Human Reproduction
Verified
Journal Article
Open access
TATurgut Aydin
Turgut Aydin
NKNadiye köroğlu
Nadiye köroğlu
EKEdis Kahraman
Edis Kahraman
NANazli Albayrak
Nazli Albayrak
EKElif Kose
Elif Kose
STUDY QUESTION: Does progesterone-based embryo transfer timing achieve live birth rates comparable to LH-surge-based timing in true natural cycle frozen embryo transfer (NC-FET)? SUMMARY ANSWER: Progesterone-based embryo transfer timing was associated with live birth rates comparable to those achieved with LH surge-based timing in true NC-FET, with no evidence of an independent association between ovulation timing strategy and live birth after adjustment for potential confounders. WHAT IS KNOWN ALREADY: In true NC-FET, embryo transfer timing is commonly scheduled according to the LH surge. However, identification of the LH surge may be challenging. Serum progesterone rise may reflect ovulation timing, yet its use as an alternative approach for scheduling embryo transfer in NC-FET cycles remains insufficiently investigated. STUDY DESIGN, SIZE, DURATION: This prospective cohort study included 490 true NC-FET cycles performed at a single tertiary IVF center between 2022 and 2025. Cycles were analyzed according to the ovulation timing strategy used for embryo transfer scheduling: progesterone-based timing (n = 286) or LH surge-based timing (n = 204). PARTICIPANTS/MATERIALS, SETTING, METHODS: Ovulation was monitored using serial ultrasound and serum hormone measurements. Embryo transfer timing was scheduled according to either detection of the LH surge or the rise in serum progesterone concentrations. The primary outcome was live birth. Adjusted relative risks were estimated using modified Poisson regression with robust standard errors, adjusting for infertility duration and etiology, endometrial thickness at transfer, embryo quality, and number of embryos transferred. Adjusted absolute risk differences were calculated using marginal standardization. An exploratory threshold-based assessment was performed on the risk-difference scale. MAIN RESULTS AND THE ROLE OF CHANCE: Live birth occurred in 162 of 286 progesterone-timed cycles (56.6%) and 106 of 204 LH-timed cycles (52.0%) (unadjusted RR 1.09, 95% CI 0.93–1.28). After adjustment, ovulation timing strategy showed no evidence of an independent association with live birth (adjusted RR 1.09, 95% CI 0.93–1.30; P = 0.264). The adjusted absolute risk difference was +4.9% (95% CI −3.8% to +13.6%). Clinical pregnancy, hCG positivity, and miscarriage rates were also comparable between groups. In exploratory analyses, follicle size measured 1 day before ovulation was positively correlated with progesterone levels on the embryo transfer day (Spearman r = 0.36, P < 0.001), and embryo-transfer-day progesterone levels were positively correlated with estradiol levels measured 1 day before ovulation (Spearman r = 0.29, P < 0.001). LIMITATIONS, REASONS FOR CAUTION: The observational design may introduce residual confounding despite statistical adjustment. The timing strategy was not randomized and reflected an evolving institutional protocol. In addition, the progesterone thresholds were derived and applied within a single-center assay environment, which may limit generalizability to other clinical settings and laboratory platforms. WIDER IMPLICATIONS OF THE FINDINGS: Progesterone-based timing may represent a feasible alternative to LH-based scheduling in true NC-FET, although confirmation in adequately powered multicenter studies is required. STUDY FUNDING/COMPETING INTEREST(S): No external funding was received for this study. The authors declare no competing interests. TRIAL REGISTRATION NUMBER: N/A.

16 December 2022 in Fertility and Sterility
Verified
Journal Article
Closed access
NANazli Albayrak
Nazli Albayrak
TATurgut Aydin
Turgut Aydin
NKNadiye Koroglu
Nadiye Koroglu


17 March 2026 in Fetal Diagnosis and Therapy
Verified
Journal Article
Open access
PDF file
NANazli Albayrak
Nazli Albayrak
CNCameron Alexander Nejat
Cameron Alexander Nejat
Background: Split cord malformation (SCM) is an uncommon congenital anomaly in which the spinal cord is longitudinally divided into two hemicords separated by a fibrous, cartilaginous, or osseous septum. Historically described as diastematomyelia or diplomyelia, the unified classification proposed by Pang et al. [Neurosurgery. 1992;31(3):451–80] distinguishes two main subtypes: type I, characterized by two hemicords within separate dural sacs divided by a rigid spur, and type II, in which hemicords share a single dural sac separated by a fibrous band. Composite SCM, involving multiple noncontiguous lesions, is exceedingly rare. Summary: Although SCM is most often recognized in childhood following neurological symptoms or cutaneous stigmata, advances in fetal ultrasonography and MRI now permit prenatal diagnosis. This shift carries significant implications for obstetric counseling, delivery planning, and multidisciplinary perinatal care. While surgical correction in infancy remains the mainstay of treatment, the growing ability to detect SCM in utero has prompted discussion of fetal therapy. Unlike open spina bifida, SCM is primarily a tethering disorder rather than a neural tube closure defect, and no evidence currently supports fetal intervention. This review covers the embryology, classification, epidemiology, clinical features, diagnostics, and management of SCM, with emphasis on prenatal imaging, obstetric considerations, and future prospects for fetal therapy. Key Messages: SCM encompasses distinct subtypes defined by dural anatomy and septum composition. Prenatal imaging has transformed antenatal detection, reshaping obstetric and multidisciplinary planning. As a tethering disorder rather than a neural tube defect, SCM does not currently warrant fetal intervention, and postnatal surgical untethering remains the standard of care.